On this episode of Global Market Bulletin TV, esteemed guest Mr. Adam Levy – CEO, President, and Director at NEXGEL (NASDAQ: NXGL) – joins Leyla Gulen to give a captivating interview that covers the recent encouraging findings from NEXGEL’s proof-of-concept study for diclofenac hydrogel patches.
Mr. Levy gave an in-depth explanation of the innovative hydrogel eye patch created by NEXGEL, which can be used to treat amblyopia – a disorder affecting vision often referred to as “lazy eye” that may affect one or both eyes.
The CEO proudly shared his upbringing as an investment banker and president of Warlock Records, then went on to discuss what he’s most passionate about in the upcoming months and years for NEXGEL.
About The Guest: Adam Levy – CEO, President, and Director at NEXGEL.
Boasting an impressive portfolio of knowledge and expertise in mergers and acquisitions, corporate finance, capital raising, strategic planning, business development and operations management – Mr. Levy is a successful entrepreneur with a proven track record of thriving businesses through both organic growth strategies as well as acquisition-led tactics.
He excels in consumer product marketing, having launched several chart-topping records during his time at Warlock Records Inc. His prowess for traditional and digital media is impressive: he has created effective television and radio ads as well as direct-to-consumer sales strategies that involve the use of e-commerce platforms.
Mr. Levy is an esteemed professional with a Bachelor’s in Business Administration from the University of California at Berkeley and a Master of Business Administration (MBA) from Stanford Graduate School of Business; additionally, he holds Certified Public Accountant credentials. His extensive experience includes involvement in numerous turnarounds as well as multiple growth initiatives.
Under his tenure as CEO and President, he has assembled a seasoned leadership team devoted to sustaining the growth of our company. In addition, he has cultivated an environment that promotes creativity and progress.
Under the guidance of Mr. Levy, the company has blazed a trail of success with remarkable growth in revenue, profitability, and market share. His enlightened vision sets up this organization to take advantage of rising industry trends while also zealously committing to its core products and services. He is unwavering when it comes to providing customers value for their dollar.
Mr. Levy is an inspirational leader in the business world, boasting a long list of achievements that have been recognized by multiple industry organizations. He not only invests capital into promising startups and mentors young entrepreneurs in building successful companies– but also contributes to various philanthropic causes such as The Giving Pledge, which strives to reduce inequality and promote charity through donations. With his impressive track record in both leadership roles and charitable contributions, Mr. Levy has earned significant respect within the business community for his genuine commitment to making positive change.
About NEXGEL
NEXGEL is a company renowned for its gentle, yet highly water-saturated hydrogels used in healthcare and consumer applications. On the trading floor, it goes by its stock symbol NXGL.
Hydrogel is an incredible blend of water and solids, with a level of flexibility that makes it ideal for transdermal application. It presents countless opportunities to revolutionize treatments in the medical field—from speeding up wound healing to delivering drugs or active ingredients across the pharmaceutical and cosmetics industries. The unfathomable potential of Hydrogel is sure to change healthcare as we know it.
For over two decades, NEXGEL has been located in Langhorne, Pennsylvania, and producing electron-beam cross-linked hydrogels. Its group of specialists has developed more than 200 distinct combinations to supply the finest quality OTC, cosmetic and natural ingredients that are delivered through a delicate patch that can be worn for long periods without any uneasiness or skin aggravation.
Learn more about NEXGEL on their official website at https://nexgel.com
Guest Inquiries
To inquire about being a guest on this show or others please contact us via the email listed here on our YouTube profile or our website at https://GlobalMarketBulletin.com
Please Like and Subscribe on YouTube to stay updated with future videos like these from other executives and CEOs and subscribe to our newsletter for up-to-date notifications and information.
